Protocol Ledger

NCT05928390 · Phase II · ACTIVE NOT RECRUITING

Pasireotide s.c. in Patients With Post-Bariatric Hypoglycaemia

Interventional Phase II clinical trial protocol NCT05928390 sponsored by RECORDATI GROUP in Rare Genetic, Women's Health, and Other, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2024-01-04 Enrollment: 93 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT05928390
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)93 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05928390
Protocol FieldVerified Registry Value
NCT IdentifierNCT05928390
Consolidated Lead SponsorRECORDATI GROUP
Therapeutic Condition CohortRare Genetic, Women's Health, and Other
Clinical Trial PhasePhase II
Overall Recruitment StatusACTIVE NOT RECRUITING
Registered Enrollment93 participants (ACTUAL)
Registered Start Date2024-01-04
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI